✦ LIBER ✦

P356 Loss of efficacy and adverse drug reactions during infliximab therapy in IBD patients are related to the appearance of anti-infliximab antibodies

✍ Scribed by A. Settesoldi; M. Giannotta; M. Milla; S. Genise; A. Santini; S. Bagnoli; V. Annese; A. Matucci; A. Vultaggio; G. Petroni; S. Pratesi; F. Nencini; E. Maggi

Book ID: 119636845
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 52 KB
Volume: 6
Category: Article
ISSN: 1873-9946
DOI: 10.1016/s1873-9946(12)60375-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.16.14 LOSS OF EFFICACY AND ADVERSE DRU

P.16.14 LOSS OF EFFICACY AND ADVERSE DRUG REACTIONS DURING INFLIXIMAB THERAPY IN IBD PATIENTS ARE RELATED TO THE APPEARANCE OF ANTI-INFLIXIMAB ANTIBODIES

✍ A. Settesoldi; M. Giannotta; S. Genise; A. Santini; S. Bagnoli; M. Milla; V. Ann 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

12 Pre-existing IgG antibodies to the Fa

12 Pre-existing IgG antibodies to the Fab region of infliximab predict efficacy and safety in IBD patients naive to anti-TNF agents

✍ Steenholdt, C.; Palarasah, Y.; Bendtzen, K.; Teisner, A.; Teisner, B.; Brynskov, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 98 KB